At a glance
ClinicalIndex Comparison RecordPhase 1Completed· 18 enrolled
Drug / intervention
Elontril +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
An Open-label, Two-period Fixed Sequence Trial to Evaluate the Effect of Multiple Doses of BI 1358894 on the Pharmacokinetics of Bupropion in Healthy Volunteers
In Brief
A Phase 1 clinical trial evaluating Elontril and BI 1358894 for Healthy. Completed, enrolled 18 participants across 1 site.
Detailed Summary
The main objective of this trial is to investigate the relative bioavailability of a single dose of bupropion when given alone (Reference) compared with co-administration (Test) with BI 1358894 in healthy volunteers.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsHealthy
CountriesGermany
Collaborators--
Timeline
Phase 1CompletedFinished
20222023202420252026
First PostedMay 2021
Enrollment StartJun 2021
Primary CompletionSep 2021
TodayJul 2026
First PostedMay 24, 2021
Enrollment StartJun 30, 2021
Primary CompletionSep 2, 2021
TodayJul 2, 2026
Enrollment to primary: 2 monthsPosted 5.1 years ago
Interventions
Elontrildrug
Tablet
BI 1358894drug
Film coated tablet